Essential Medicine List, Policies, and the World Health Organization

Muhammad Atif; Iram Malik; Dalia Dawoud; Anwar Gilani; Naseer Ahmed; Zaheer-Ud-Din Babar

Essential Medicine List, Policies, and the World Health Organization

Muhammad Atif, Iram Malik, Dalia Dawoud, Anwar Gilani, Naseer Ahmed, Zaheer-Ud-Din Babar

Research output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary › peer-review

Abstract

National policy on essential medicines is one of the main pillars of global health agenda. The Nairobi Conference on the Rational Use of Drugs, held in 1985, was the first international conference on policies on essential medicines. Over the years, World Health Organization has widely supported most low- and middle-income countries (LMICs) in the development and subsequent implementation of national policies on essential medicines.Implementation of these policies has resulted in their easy availability, better affordability, and better quality in LMICs.

Original language	English
Title of host publication	Encyclopedia of Pharmacy Practice and Clinical Pharmacy
Editors	Zaheer-Ud-Din Babar
Publisher	Elsevier Inc.
Pages	239-249
Number of pages	11
Volume	2
Edition	1st
ISBN (Electronic)	9780128127360
ISBN (Print)	9780128127353
Publication status	Published - 20 Jun 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://www.sciencedirect.com/science/article/pii/B9780128127353003447Licence: Unspecified

Cite this

@inbook{f123af3071e74c73b2a612538042aa05,

title = "Essential Medicine List, Policies, and the World Health Organization",

abstract = "National policy on essential medicines is one of the main pillars of global health agenda. The Nairobi Conference on the Rational Use of Drugs, held in 1985, was the first international conference on policies on essential medicines. Over the years, World Health Organization has widely supported most low- and middle-income countries (LMICs) in the development and subsequent implementation of national policies on essential medicines.Implementation of these policies has resulted in their easy availability, better affordability, and better quality in LMICs.",

keywords = "Development of essential drug policies, Essential drug policy, Essential medicines, Impact of essential drug policy, Low and middle income countries, Stakeholders involved in essential drug policies, WHO model list of essential medicines",

author = "Muhammad Atif and Iram Malik and Dalia Dawoud and Anwar Gilani and Naseer Ahmed and Zaheer-Ud-Din Babar",

year = "2019",

month = jun,

day = "20",

language = "English",

isbn = "9780128127353",

volume = "2",

pages = "239--249",

editor = "Zaheer-Ud-Din Babar",

booktitle = "Encyclopedia of Pharmacy Practice and Clinical Pharmacy",

publisher = "Elsevier Inc.",

address = "Netherlands",

edition = "1st",

}

TY - CHAP

T1 - Essential Medicine List, Policies, and the World Health Organization

AU - Atif, Muhammad

AU - Malik, Iram

AU - Dawoud, Dalia

AU - Gilani, Anwar

AU - Ahmed, Naseer

AU - Babar, Zaheer-Ud-Din

PY - 2019/6/20

Y1 - 2019/6/20

N2 - National policy on essential medicines is one of the main pillars of global health agenda. The Nairobi Conference on the Rational Use of Drugs, held in 1985, was the first international conference on policies on essential medicines. Over the years, World Health Organization has widely supported most low- and middle-income countries (LMICs) in the development and subsequent implementation of national policies on essential medicines.Implementation of these policies has resulted in their easy availability, better affordability, and better quality in LMICs.

AB - National policy on essential medicines is one of the main pillars of global health agenda. The Nairobi Conference on the Rational Use of Drugs, held in 1985, was the first international conference on policies on essential medicines. Over the years, World Health Organization has widely supported most low- and middle-income countries (LMICs) in the development and subsequent implementation of national policies on essential medicines.Implementation of these policies has resulted in their easy availability, better affordability, and better quality in LMICs.

KW - Development of essential drug policies

KW - Essential drug policy

KW - Essential medicines

KW - Impact of essential drug policy

KW - Low and middle income countries

KW - Stakeholders involved in essential drug policies

KW - WHO model list of essential medicines

UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85075712120&origin=inward&txGid=2390f2907cd508156d9b78e3cce8675b

M3 - Entry for encyclopedia/dictionary

SN - 9780128127353

VL - 2

SP - 239

EP - 249

BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy

A2 - Babar, Zaheer-Ud-Din

PB - Elsevier Inc.

ER -

Essential Medicine List, Policies, and the World Health Organization

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this